Haemoglobinopathies congenital Completed Phase 2 Trials for Deferoxamine (DB00746)

Also known as: Haemoglobinopathies / Haemoglobinopathy / Hemoglobinopathy / Hemoglobinopathies / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00000595Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional HemochromatosisTreatment